This week’s cyber recap covers AI risks, supply-chain attacks, major breaches, DDoS spikes, and critical vulnerabilities security teams must track.

The percentage of teachers who are using artificial intelligence-driven tools in their classrooms nearly doubled between 2023 and 2025, according to data from the EdWeek Research Center. In 2023, a ...

U.S. jobs data for December and ISM data on U.S. manufacturing and services-sector activity will be the key focus in the coming week as investors gauge the health of the economy and the likely timing ...

Focus will center on a smattering of U.S. data releases, particularly GDP, as investors gauge the performance of the U.S. economy after key economic figures were delayed during the recent government ...

We all need room…but how much room do we need to make? In the current gaming age we live in, players not only have to worry about the various games they play and whether they’ll enjoy them, but also ...

Google is ending its dark web report, with scans stopping Jan. 15, 2026. Google says it is shifting to tools with clearer, actionable guidance. Other dark web monitoring tools and scanners are still ...

Google’s dark web reports gave users important info, but not enough “helpful next steps.” Google’s dark web reports gave users important info, but not enough “helpful next steps.” is a news writer ...

Google began offering “dark web reports” a while back, but the company has just announced the feature will be going away very soon. In an email to users of the service, Google says it will stop ...

I didn't always take online security seriously. I made basic mistakes, like using the same password for all my accounts, logging onto public WiFI networks without a VPN and giving out my email and ...

PythoC lets you use Python as a C code generator, but with more features and flexibility than Cython provides. Here’s a first look at the new C code generator for Python. Python and C share more than ...

In my last note on Altimmune, Inc. (ALT) shared in late August, I made the bull case for its stock. I discussed the Gaithersburg, Maryland based biotech's lead and only drug candidate, pemvidutide, ...